Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 20048706)

1.

New virologic reagents for neutralizing antibody assays.

Ochsenbauer C, Kappes JC.

Curr Opin HIV AIDS. 2009 Sep;4(5):418-25. doi: 10.1097/COH.0b013e32832f011e. Review.

PMID:
20048706
2.

Impact of host cell variation on the neutralization of HIV-1 in vitro.

Polonis VR, Schuitemaker H, Bunnik EM, Brown BK, Scarlatti G.

Curr Opin HIV AIDS. 2009 Sep;4(5):400-7. doi: 10.1097/COH.0b013e32832edc50. Review.

PMID:
20048704
3.

Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.

Xiao Y, Dong X, Chen YH.

Immunol Res. 2002;25(3):193-200. Review.

PMID:
12018459
4.

Neutralization of HIV-1 by antibody.

Sattentau QJ.

Curr Opin Immunol. 1996 Aug;8(4):540-5. Review.

PMID:
8794008
5.

Specificities of broadly neutralizing anti-HIV-1 sera.

Binley J.

Curr Opin HIV AIDS. 2009 Sep;4(5):364-72. doi: 10.1097/COH.0b013e32832e06fe. Review.

PMID:
20048699
6.

Role of neutralizing antibodies in protective immunity against HIV.

Srivastava IK, Ulmer JB, Barnett SW.

Hum Vaccin. 2005 Mar-Apr;1(2):45-60. Epub 2005 Mar 17. Review.

PMID:
17038830
7.

HIV-1: the confounding variables of virus neutralization.

Nara PL, Lin G.

Curr Drug Targets Infect Disord. 2005 Jun;5(2):157-70. Review.

PMID:
15975021
8.

The role of neutralizing antibodies in HIV infection.

Humbert M, Dietrich U.

AIDS Rev. 2006 Apr-Jun;8(2):51-9. Review.

PMID:
16848273
9.

Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.

Srivastava IK, Ulmer JB, Barnett SW.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S33-52. Review.

PMID:
15285704
10.

Challenges for structure-based HIV vaccine design.

Schief WR, Ban YE, Stamatatos L.

Curr Opin HIV AIDS. 2009 Sep;4(5):431-40. doi: 10.1097/COH.0b013e32832e6184. Review.

PMID:
20048708
11.

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

Polonis VR, Brown BK, Rosa Borges A, Zolla-Pazner S, Dimitrov DS, Zhang MY, Barnett SW, Ruprecht RM, Scarlatti G, Fenyƶ EM, Montefiori DC, McCutchan FE, Michael NL.

Virology. 2008 Jun 5;375(2):315-20. doi: 10.1016/j.virol.2008.02.007. Epub 2008 Mar 25. Review.

12.

Bioorganic approaches towards HIV vaccine design.

Wang LX.

Curr Pharm Des. 2003;9(22):1771-87. Review.

PMID:
12871196
13.

Antibody neutralization of HIV-1.

Poignard P, Klasse PJ, Sattentau QJ.

Immunol Today. 1996 May;17(5):239-46. Review.

PMID:
8991386
14.

Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics.

Gupta S, Devanarayan V, Finco D, Gunn GR 3rd, Kirshner S, Richards S, Rup B, Song A, Subramanyam M.

J Pharm Biomed Anal. 2011 Jul 15;55(5):878-88. doi: 10.1016/j.jpba.2011.03.038. Epub 2011 Apr 6. Review.

PMID:
21531522
15.
16.

Development and optimization of neutralizing antibody assays to monitor clinical immunogenicity.

Civoli F, Kroenke MA, Reynhardt K, Zhuang Y, Kaliyaperumal A, Gupta S.

Bioanalysis. 2012 Nov;4(22):2725-35. doi: 10.4155/bio.12.239. Review.

PMID:
23210655
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk